Case study examining the impact of German reunification on life expectancy

Similar documents
508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

The health economic landscape of cancer in Europe

An analysis of structural changes in the consumption patterns of beer, wine and spirits applying an alternative methodology

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Key Highlights continued

WCPT COUNTRY PROFILE December 2017 SWEDEN

Allied Health: Sustainable Integrated Health Care for all Australians

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016

The OECD Health Care Quality Indicators Project

European Collaboration on Dementia. Luxembourg, 13 December 2006

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2017

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Smokefree Policies in Europe: Are we there yet?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

LEBANON. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

GERMANY. WCPT COUNTRY PROFILE December 2018

Gender differences in competitive preferences: new cross-country empirical evidence

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Table 15.1 Summary information for kidney cancer in Ireland, Ireland RoI NI female male female male female male % of all new cancer cases

NBER WORKING PAPER SERIES ALCOHOL CONSUMPTION AND TAX DIFFERENTIALS BETWEEN BEER, WINE AND SPIRITS. Working Paper No. 3200

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Alcohol-related harm in Europe and the WHO policy response

UK bowel cancer care outcomes: A comparison with Europe

Engagement in language assessment / Regions of Europe

ESS Workshop, The Hague, March


Louis-André Vallet (CNRS) Observatoire Sociologique du Changement (UMR CNRS & Sciences Po Paris)

Table 9.1 Summary information for stomach cancer in Ireland,

artus EBV QS-RGQ Kit Performance Characteristics May 2012 Sample & Assay Technologies Analytical sensitivity plasma

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

CARDIOVASCULAR DISEASE AND DIABETES:

ETB Data. there was. compared

Q1 What age are you?

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Multivariate relationships. Week 6 22 February, 2016 Prof. Andrew Eggers

Causality and Treatment Effects

EUVAC.NET A surveillance network for vaccine-preventable diseases

What is the extent of gender bias in bioinformatics?

The Urgency of the Situation: The Cost of Childhood Obesity for Society

Appendix F: Test-Curriculum Matching Analysis

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

PRODUCT INFORMATION. New Reagents for Dako CoverStainer. Choose the H&E staining intensity you want.

Where we stand in EFORT

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Table 7.1 Summary information for lung cancer in Ireland,

The Risk of Alcohol in Europe. Bridging the Gap June 2004

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Table 6.1 Summary information for colorectal cancer in Ireland,

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

To provide information on the new standard, a number of EOG members formed a committee to compile information on the following basis:

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Real Life, Real PD Survey

FORUM FOR AEROSPACE NDT BOARDS

Johns Hopkins individualized Health Initiative

This document is a preview generated by EVS

The use of cluster analysis to identify factors that influence the establishment of Health Technologies Assessment (HTA) agencies

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

2017 ICF GLOBAL CONSUMER AWARENESS STUDY

GLP in the European Union Ecolabel detergents, GLP and accreditation

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

HPV, Cancer and the Vaccination Programme

Amoxicillin 40 mg Clavulanic acid 10 mg. Clavulanic acid 10 mg. Clavulanic acid 10 mg. Clavulanic acid 10 mg

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

ERNDIM QAP for qualitative urinary organic acid analysis. Annual Report 2003 (Sheffield)

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

This document is a preview generated by EVS

Palliative nursing care of children and young people across Europe

BioPlex 2200 Infectious Disease Panels

Introduction to Qualitative Comparative Analysis (QCA)

STATS Relationships between variables: Correlation

The influence of the preference for menthol cigarettes on smoking prevalence trends

Transcription:

Supplementary Materials 2 Case study examining the impact of German reunification on life expectancy Table A1 summarises our case study. This is a simplified analysis for illustration only and does not include the whole range of tests and comparisons with alternative methods that a robust analysis would require. Table A1: Outline of case-study (OECD Organisation of Economic Co-operation and Development. GDP Gross Domestic Product) Treated unit West Germany Potential control units OECD countries Outcome variable Life expectancy Predictor variable GDP Date of implementation 1990 Pre-implementation periods 1960-1989 Post-implementation periods 1990-2004 The syntax and data (Stata format) are available as Supplementary Materials. The syntax includes details on obtaining and constructing the dataset. The purpose of the case study is to use SCM to evaluate the impact of German reunification on life expectancy in West Germany by creating a synthetic control to represent life expectancy trends as if West Germany had not experienced reunification. Step 1 - Theoretical understanding The first step in the SCM process is to make the theory and context around the intervention explicit. In particular, the characteristics chosen to match the real and synthetic treated units should be theory-driven (i.e. factors associated with the outcome variable). Although the previous trend in the outcome variable can be the most important variable in determining the weighting of the potential control units in the synthetic control unit, it is important to include other predictor variables. This ensures that the synthetic control unit is as similar as possible in important characteristics as well as being able to replicate the pre-implementation trend for the outcome variable. In our simplified example we focus on GDP per capita as our additional predictor as this is hypothesised as being a possible cause of post reunification falls in life expectancy.

Detailed knowledge of the intervention is also necessary in order to ensure that any of the potential control units in the donor pool have not also been affected by the intervention. If a potential control unit has been affected by the intervention or similar interventions designed to achieve the same effect then the effect of the intervention may be diluted if the contaminated unit is retained in the donor pool. Because reunification is such an unusual event we can be confident that the common shocks assumption is satisfied. Step 2 Identification of potential control units The SCM builds a synthetic control from the values of the outcome and predictor variables of a range of potential controls known as the donor pool. The initial donor pool tends to comprise a logical geographical or politico-economic grouping of countries or states such as all the states of the United States, countries of the OECD, or member states of the European Union. This is often because similar data are available for the grouping but also because membership of the group may suggest common characteristics. Our case study starts with the other 23 countries in the OECD at the time of German reunification. Potential control units that are not sufficiently similar to the treated unit should be excluded from the donor pool as the objective is to make a synthetic West Germany. If countries which are dissimilar to West Germany are retained in the pool there is more scope for unmeasured confounding. It may seem unimportant to exclude inappropriate potential controls from the pool as they would likely receive a zero weighting in the selection process. However, if the donor pool is large, the noise from the outcome variable across the various countries may result in over-fitting in the pre-implementation period as virtually any trend could be matched. The resulting weights selected would not represent the best synthetic counterfactual. It should be noted that criteria for exclusion are set by the researcher and to date no clear consensus has been established as to what the process should be for excluding dissimilar units from the pool of potential donors. It is, therefore, essential to report clearly the criteria used and qualitatively assess the excluded units. Sensitivity analysis can be undertaken to determine how robust results are to various combinations of donor pool. In their study of German reunification Abadie et al (reference 3 in the main manuscript) excluded 7 countries from the pool for reasons of size (Iceland and Luxembourg), much lower GDP (Turkey) and economic shocks in the post reunification period (Canada, Finland, Sweden, and Ireland). This left 16 countries in the pool Australia, Austria, Belgium, Denmark, France, Greece, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal,

Spain, Switzerland, the United Kingdom, and the United States. We excluded Greece as our data source only had life expectancy for Greece back to 1981, leaving a pool of 15. We explored the trend in the mean life expectancy and GDP graphically (see Do file in Supplementary Materials) and the 5 country pool previously used was closer to the trend for West Germany. We, therefore, decided to restrict our pool to Austria, Japan, Switzerland, Netherlands and the United States. In a full analysis the researcher could conduct sensitivity analysis to determine the effect of this restriction. Step 3 Develop the synthetic control country a synthetic control West Germany. Using data from the pre-reunification period only we use the Synthetic Control software to develop a weighted average from the 5 country pool. Reunification occurred in 1990 so the pre intervention period is 1960-1989. Importantly, we do not access outcome data post 1990 at this stage to reduce the likelihood of our synthetic control creation being influenced by the result. The aim is to minimise the difference in the outcome trend between West Germany and its synthetic control. This can be assessed visually, as well as being judged by calculating the difference between them. The synthetic control method minimises the root mean square prediction error (RMSPE) based on pre-intervention variables for those countries in the pool. Given the aim to find the best fit to the outcome variable in the pre-intervention period and the fact that the researcher remains blinded to the post-intervention outcome there is some flexibility in how to include the outcome variables in the analysis. Best practice on how to specify the variables is still lacking. Several approaches are possible including (1) using each year of the outcome variable as a separate variable; (2) using the final pre-intervention outcome variable; and (3),using an average over the pre-intervention period. The first approach is thought to lead to overfitting so will not be used here. We have used the second approach and a form of the third in this case study. Using the values of the predictors (GDP and Life expectancy) at the end of the preintervention period (in our case 1989) gives the pre-intervention fit shown in the top row in Figure A1. Given the fit for GDP and life expectancy shown from the first approach we then looked at using some averages (i.e. the third approach). As in our first iteration above, the match for GDP per capita was good until roughly 1967 and for life expectancy until 1983 we included variables representing each of these periods. Overall for life expectancy we included three variables (average from 1960 to 1969, from 1970 to 1982 and from 1983 to 1989) and for GDP per capita we included two (1960 to 1966 and 1967 to 1989). Hence there are now

five variables. The bottom row of Figure A1 shows the fit of this specification and the RMSPE and weightings of predictor variables and control units are shown in Table A2. Figure A1: Two approaches to finding a synthetic control for West Germany s life expectancy in the pre-implementation period (pre 1990). The top row shows the results of fitting using only the 1989 values for life expectancy and Gross Domestic Product (GDP). The second row shows the results when averages are used for life expectancy (from 1960 to 1969, from 1970 to 1982 and from 1983 to 1989) and for GDP per capita (1960 to 1966 and 1967 to 1989). The two approaches give RMSPE, weightings of predictor variables and country weightings as set out in Table A2.

Table A2: Root Mean Square Prediction Error (RMSPE), weightings of predictor variables and country weightings (GDP: Gross Domestic Product) Approach Using 1989 GDP and life Using averages expectancy RMSPE 0.46 0.26 Weighting of variables Life expectancy 95% 32% GDP 5% 68% Weighting of control units Austria 51% 70% Japan 6% - Netherlands 14% - Switzerland 9% 19% USA 20% 11% The averaging approach produces a better pre-implementation fit so this was the approach we adopted. Although it may feel inappropriate to be exploring different approaches to finding pre-implementation fit, recall that we are still blinded to the post-implementation data and that each of the countries in the control group is a close match to West Germany so may have been considered an appropriate control in a case comparison type study. In a full analysis we would include more predictors and try and further minimise the RMPSE. Step 4 Run outcome analysis Once an acceptable fit has been obtained between actual and synthetic West Germany, the analysis is run using the full pre and post-implementation data set, presented graphically and results retained for robustness checks. Step 5 - Present results A figure (Figure A2) is produced showing the real and synthetic West Germany graphically with a line at the date of the intervention. Ideally, there should be a good fit to the left of the line in the pre-intervention period (from stages 1 to 3) and, if the intervention has an effect, there should be a gap between the real and synthetic unit after the date of the intervention. In the case of life expectancy there appears to be a small lower life expectancy post reunification in West Germany than its synthetic counterpart. The gap at particular points in time or over the full post-implementation period can be calculated arithmetically. The reduction in life expectancy at the end of the post-implementation period (2003) in West

Germany was 0.4 years, so any effect, if real, is small. The figure also confirms the previous result that GDP fell after reunification. Figure A2 Life expectancy and GDP for West Germany and its synthetic control (GDP: Gross Domestic Product, vertical line represents the date of the implementation) Step 6 Run robustness checks What confidence should we place in the life expectancy results? Standard statistical inference is not appropriate with SCM as there are generally insufficient units to estimate a distribution, there is no randomization between treated and control, and probabilistic sampling is not employed to select sample units. Instead various robustness checks can be undertaken to improve causal inference. The most common check is known as an in-space placebo test where each potential control unit in turn is used as the treated unit and its own synthetic control developed (from a pool excluding the actual treated country). If the gap for the real treated unit is a true intervention effect then the gap should be large compared to the gap for all the placebo analyses. This is not the case in our example.

Figure A3: In-space placebo analysis. The dark line represents the gap between the lifeexpectancy for West Germany and its synthetic control, the lighter lines represent the gaps when the analysis is run using each other country in the donor pool as the treated unit. The vertical line represents the date of implementation. It is also possible to do a similar falsification exercise using other times of implementation or other outcomes (in-time and in-outcome placebo tests). Another sensitivity-type test undertaken in some studies using SCM includes sparse synthetic control, where the number of control units is reduced from the original specification step by step and the effect on weighting of donor units and quality of pre-implementation fit assessed. Although only one of the health-related studies used this approach it is useful to gauge the difference in result using the weighted synthetic control compared to a single control unit. A further possibility is leave one out analysis where each country making up the control unit is removed one at a time from the donor pool. This allows the sensitivity of the result to the inclusion of a particular control unit to be assessed. A further stage in the placebo analysis is to calculate a ratio of the post-implementation RMSPE to the pre-intervention RMSPE. This is a measure of how big the gap between real treated unit and synthetic control is after the intervention date as a function of the gap before the intervention. If the fit between the actual and synthetic treated units before the intervention is not good the ratio will be smaller. The larger the ratio, the more convincing the evidence that the intervention has had an effect. As the table below shows West Germany s RMSPE ratio is not the lowest. However confirming the visual results in Figure

A3 this is not because of a poor pre intervention fit but because post intervention it is little changed. Table A3: Pre and post implementation Root Mean Square Prediction Error (RMSPE) for West Germany and other countries in the donor pool (in-space placebo analysis) Pre implementation RMSPE Post implementation RMSPE Ratio post / pre Austria 1.51 0.82 0.55 Japan 2.08 2.81 1.36 Netherlands 1.80 1.91 1.06 Switzerland 1.79 2.70 1.51 USA 0.86 2.03 2.36 West Germany 0.26 0.25 0.96